Therapeutic hypothermia and N-PASS; results from implementation in a level 3 NICU.


Journal

Early human development
ISSN: 1872-6232
Titre abrégé: Early Hum Dev
Pays: Ireland
ID NLM: 7708381

Informations de publication

Date de publication:
10 2019
Historique:
received: 29 05 2019
revised: 22 07 2019
accepted: 23 07 2019
pubmed: 30 7 2019
medline: 6 2 2020
entrez: 30 7 2019
Statut: ppublish

Résumé

Neonates that have been subjected to perinatal asphyxia and fulfill criteria for therapeutic hypothermia are cooled to 33.5 °C for 72 h. There is no consensus regarding sedation and analgesic use during hypothermia, but there is evidence supporting the importance of pain relief and adequate sedation. There is a need for assessment of the neonates need for pain relief and sedation, and for adjustments of medication to ensure adequate treatment. There are many different scoring tools available. We found the N-PASS (Neonatal Pain, Agitation and Sedation Scale) scoring tool to be the most suitable for this patient group as it assesses both pain and sedation. We translated the scoring tool according to guidelines published by Wilder et al., and scored neonates treated with therapeutic hypothermia. Sedation and analgesia were adjusted according to scoring results. At the end of the study a questionnaire was filled out by the nurses in charge of this group of patients. Both pain and sedation scores did not reach the desired levels until day 3. The nurses reported a high level of satisfaction (79.7% were extremely of very satisfied), and 96.7% of the nurses found the neonates to be better pain relieved after the initiation of the study. The implementation of the N-PASS scoring tool in our unit has been successful, and has led to better pain relief and sedation than before the implementation.

Sections du résumé

BACKGROUND
Neonates that have been subjected to perinatal asphyxia and fulfill criteria for therapeutic hypothermia are cooled to 33.5 °C for 72 h. There is no consensus regarding sedation and analgesic use during hypothermia, but there is evidence supporting the importance of pain relief and adequate sedation. There is a need for assessment of the neonates need for pain relief and sedation, and for adjustments of medication to ensure adequate treatment. There are many different scoring tools available. We found the N-PASS (Neonatal Pain, Agitation and Sedation Scale) scoring tool to be the most suitable for this patient group as it assesses both pain and sedation.
METHODS
We translated the scoring tool according to guidelines published by Wilder et al., and scored neonates treated with therapeutic hypothermia. Sedation and analgesia were adjusted according to scoring results. At the end of the study a questionnaire was filled out by the nurses in charge of this group of patients.
RESULTS
Both pain and sedation scores did not reach the desired levels until day 3. The nurses reported a high level of satisfaction (79.7% were extremely of very satisfied), and 96.7% of the nurses found the neonates to be better pain relieved after the initiation of the study.
CONCLUSION
The implementation of the N-PASS scoring tool in our unit has been successful, and has led to better pain relief and sedation than before the implementation.

Identifiants

pubmed: 31357084
pii: S0378-3782(19)30274-9
doi: 10.1016/j.earlhumdev.2019.104828
pii:
doi:

Types de publication

Evaluation Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

104828

Informations de copyright

Copyright © 2019 Elsevier B.V. All rights reserved.

Auteurs

Inger Louise Üner (IL)

Department of Neonatology, Oslo University Hospital, Norway. Electronic address: INGUNE@ous-hf.no.

Tove Johansen (T)

Department of Neonatology, Oslo University Hospital, Norway. Electronic address: UXOVSE@ous-hf.no.

Julie Dahle (J)

Department of Neonatology, Oslo University Hospital, Norway. Electronic address: UXDAJU@ous-hf.no.

Mette Persson (M)

Department of Neonatology, Oslo University Hospital, Norway. Electronic address: UXPMET@ous-hf.no.

Tom Stiris (T)

Department of Neonatology, Oslo University Hospital, Norway; Faculty of Medicine, University of Oslo, Norway. Electronic address: UXOMST@ous-hf.no.

Jannicke Hanne Andresen (JH)

Department of Neonatology, Oslo University Hospital, Norway. Electronic address: jandrese@ous-hf.no.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH